Elaine M. Hylek, MD

Publications

• Published on 2/27/2023

  Go AS, Al-Khatib SM, Desvigne-Nickens P, Bansal N, Bushnell CD, Fang MC, Freeman JV, Gage BF, Hanke T, Hylek EM, Lopes RD, Noseworthy PA, Reddy VY, Singer DE, Thomas KL, True Hills M, Turakhia MP, Zieman SJ, Cooper LS, Benjamin EJ. Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Stroke. 2023 Mar; 54(3):e75-e85. PMID: 36848427.

  Read at: PubMed
• Published on 12/1/2022

  Hylek EM. Catheter-Directed Treatment of Submassive Pulmonary Embolism-A Cautious Step Closer? JAMA Cardiol. 2022 Dec 01; 7(12):1197-1198. PMID: 36260318.

  Read at: PubMed
• Published on 9/19/2022

  Al-Khatib SM, Wojdyla DM, Granger CB, Wallentin L, Garcia DA, Hijazi Z, Held C, Alexander JH, Vinereanu D, Flaker GC, Hylek EM, Lopes RD. Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Circulation. 2022 Sep 20; 146(12):958-960. PMID: 36121911.

  Read at: PubMed
• Published on 1/5/2022

  Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, Patel MR, Wallentin L, Alexander JH, Cecilia Bahit M, Benz AP, Bohula EA, Chao TF, Dyal L, Ezekowitz M, A A Fox K, Gencer B, Halperin JL, Hijazi Z, Hohnloser SH, Hua K, Hylek E, Toda Kato E, Kuder J, Lopes RD, Mahaffey KW, Oldgren J, Piccini JP, Ruff CT, Steffel J, Wojdyla D, Granger CB. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex. Circulation. 2022 01 25; 145(4):242-255. PMID: 34985309.

  Read at: PubMed
• Published on 11/15/2021

  Weitz JI, Strony J, Ageno W, Gailani D, Hylek EM, Lassen MR, Mahaffey KW, Notani RS, Roberts R, Segers A, Raskob GE. Milvexian for the Prevention of Venous Thromboembolism. N Engl J Med. 2021 12 02; 385(23):2161-2172. PMID: 34780683.

  Read at: PubMed
• Published on 10/21/2021

  Rasmussen PV, Hylek E. Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants. Eur Heart J. 2021 10 21; 42(40):4138-4140. PMID: 34347053.

  Read at: PubMed
• Published on 7/1/2021

  Albers GW, Bernstein R, Brachmann J, Camm AJ, Fromm P, Goto S, Granger CB, Hohnloser SH, Hylek E, Krieger D, Passman R, Pines JM, Kowey P. Reexamination of the Embolic Stroke of Undetermined Source Concept. Stroke. 2021 08; 52(8):2715-2722. PMID: 34192898.

  Read at: PubMed
• Published on 3/1/2021

  Pol T, Hijazi Z, Lindbäck J, Alexander JH, Bahit MC, De Caterina R, Eikelboom JW, Ezekowitz MD, Gersh BJ, Granger CB, Hylek EM, Lopes R, Siegbahn A, Wallentin L. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. Open Heart. 2021 03; 8(1). PMID: 33741689.

  Read at: PubMed
• Published on 9/15/2020

  Hylek EM. The importance of adherence and persistence in the elderly atrial fibrillation patient. Eur Heart J Suppl. 2020 Sep; 22(Suppl I):I38-I42. PMID: 33088233.

  Read at: PubMed
• Published on 9/1/2020

  Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Alings M, De Caterina R, Eikelboom JW, Ezekowitz MD, Held C, Huber K, Hylek EM, Granger CB, Lopes RD, Vinereanu D, Siegbahn A, Wallentin L. Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials. JAMA Netw Open. 2020 09 01; 3(9):e2015943. PMID: 32936298.

  Read at: PubMed

View 265 more publications: View full profile at BUMC